2 Robert Speck Pkwy #740, Mississauga, ON Toll-Free: 1-855-828-2914 info.canada@msnlabs.ca

Our Capabilities

Speed, consistency and depth of expertise — from complex chemistry to finished medicines.

What we do

Research & Development

An integrated R&D centre covers both API and formulation development, with a pilot plant for scale-up. Our scientists specialise in niche generics, complex and difficult-to-make products, and novel drug-delivery systems.

Manufacturing

19 API and 8 finished-dosage facilities across India, the USA, Indonesia and the UAE, built for cGMP compliance with a high degree of process automation.

Quality & Regulatory

Facilities hold approvals and accreditations from regulators including Health Canada, US FDA, UK MHRA, EU authorities, Brazil’s ANVISA and the WHO. Regulatory filings span the Canada, US, Europe and Japan.

Complex Chemistry

Expertise in high-potency oncology molecules, complex peptides, iron complexes, polymer chemistry and advanced characterisation.

Dosage-form Technologies

Immediate, extended, sustained, delayed and modified-release (osmotic) products, multi-layer tablets, sublinguals, pellets, granules and ophthalmic solutions.

Supply Chain

Backward integration into APIs, large-scale capacity and dynamic supply-chain management support dependable, continuous supply.

Integrated model

Control at every step of the value chain

As MSN makes its own active ingredients, we ensure quality, cost and supply from the first chemical step to the final package.

19

API manufacturing facilities

8

Finished-dosage facilities

600+

APIs in portfolio

400+

Formulations

Let’s work together

Questions about our products or partnership opportunities in Canada? Our team is here to help.